FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2024-2027 May 7, 2009 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Tonino, P. A.L. PubMed Citation

To the Editor: Tonino et al. (Jan. 15 issue)¹ report on the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study (ClinicalTrials.gov number, NCT00267774 [ClinicalTrials.gov] ), which compared an angiography-only strategy with routine measurement of fractional flow reserve (FFR) in addition to angiography in patients with multivessel disease who were undergoing percutaneous coronary intervention (PCI). The authors report a lower 1-year rate of adverse events with angiography guided by FFR measurement. Although their findings provide an encouraging perspective on the relative safety of selective stenting with the use of FFR measurement, some aspects of the trial design may have led . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.